Enzyme Is the Name—Adapter Is the Game
Cells · 25.07.2024 · 13 (15) · 1249
DOI: 10.3390/cells13151249 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 25.07.2024. Verfasst von Michael Huber und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Molecular Immunology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany. Hauptthemen laut MEDLINE: Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Research Foundation (DFG).
Abstract (Originalsprache)
Signaling proteins in eukaryotes usually comprise a catalytic domain coupled to one or several interaction domains, such as SH2 and SH3 domains. An additional class of proteins critically involved in cellular communication are adapter or scaffold proteins, which fulfill their purely non-enzymatic functions by organizing protein–protein interactions. Intriguingly, certain signaling enzymes, e.g., kinases and phosphatases, have been demonstrated to promote particular cellular functions by means of their interaction domains only. In this review, we will refer to such a function as "the adapter function of an enzyme". Though many stories can be told, we will concentrate on several proteins executing critical adapter functions in cells of the immune system, such as Bruton´s tyrosine kinase (BTK), phosphatidylinositol 3-kinase (PI3K), and SH2-containing inositol phosphatase 1 (SHIP1), as well as in cancer cells, such as proteins of the rat sarcoma/extracellular signal-regulated kinase (RAS/ERK) mitogen-activated protein kinase (MAPK) pathway. We will also discuss how these adaptor functions of enzymes determine or even undermine the efficacy of targeted therapy compounds, such as ATP-competitive kinase inhibitors. Thereby, we are highlighting the need to develop pharmacological approaches, such as proteolysis-targeting chimeras (PROTACs), that eliminate the entire protein, and thus both enzymatic and adapter functions of the signaling protein. We also review how genetic knock-out and knock-in approaches can be leveraged to identify adaptor functions of signaling proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Biochemistry and Molecular Immunology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
- Institute of Molecular Medicine and Cell Research, IMMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
- German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
- Center for Biological Signalling Studies BIOSS, University of Freiburg, 79104 Freiburg, Germany.
ORCID-Profile: Michael Huber, Tilman Brummer
Förderung
- Deutsche Forschungsgemeinschaft
- German Research Foundation (DFG)
Zitieren
APA
Huber, M., & Brummer, T. (2024). Enzyme Is the Name—Adapter Is the Game. Cells, 13(15), 1249. https://doi.org/10.3390/cells13151249
Vancouver
Huber M, Brummer T. Enzyme Is the Name—Adapter Is the Game. Cells. 2024;13(15):1249. doi:10.3390/cells13151249
BibTeX
@article{Huber2024,
author = {Huber, Michael and Brummer, Tilman},
title = {Enzyme Is the Name—Adapter Is the Game},
journal = {Cells},
year = {2024},
volume = {13},
number = {15},
pages = {1249},
doi = {10.3390/cells13151249}
}
EUVIMED